Accueil >
Publications >
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers

1 avr. 2018EMBO Molecular Medicine

DOI : 10.15252/emmm.201708163

Auteurs

Mélanie Mahe, Florent Dufour, Hélène Neyret‐Kahn, Aura Moreno‐Vega, Claire Beraud, Mingjun Shi, Imene Hamaidi, Virginia Sanchez‐Quiles, Clementine Krucker, Marion Dorland‐Galliot, Elodie Chapeaublanc, Remy Nicolle, Hervé Lang, Celio Pouponnot, Thierry Massfelder, François Radvanyi, Isabelle Bernard‐Pierrot